开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09939 开拓药业-B

劳动节休市 04-30 16:08:11

2.840

-0.040

-1.39%

最高2.870	最低2.740	成交量221.45万
今开2.850	昨收2.880	日振幅4.51%
总市值14.17亿	流通市值14.17亿	总股本4.99亿
成交额617.62万	换手率0.44%	流通股本4.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"开拓药业-B","latestPrice":2.84,"timestamp":1777536491493,"preClose":2.88,"halted":0,"volume":2214500,"delay":0,"changeRate":-0.013888888888888902,"floatShares":499000000,"shares":499000000,"eps":-0.5107327903347124,"marketStatus":"劳动节休市","change":-0.04,"latestTime":"04-30 16:08:11","open":2.85,"high":2.87,"low":2.74,"amount":6176215,"amplitude":0.045139,"askPrice":2.85,"askSize":28000,"bidPrice":2.84,"bidSize":16000,"shortable":0,"etf":0,"ttmEps":-0.5096927416321926,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":1590076800000,"exchange":"SEHK","adjPreClose":2.88,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":1.3365320779527454,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939","defaultTab":"news","newsList":[{"id":"2632650371","title":"中国医药新注册《医药医疗健康业务数据分析软件V1.0》等4个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2632650371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632650371?lang=zh_cn&edition=full","pubTime":"2026-05-01 01:56","pubTimestamp":1777571773,"startTime":"0","endTime":"0","summary":"证券之星消息，近日中国医药新注册了4个项目的软件著作权，包括《医药医疗健康业务数据分析软件V1.0》、《审计追责报告汇总软件V1.0》、《销售预测分析系统V1.0》、《投资报告管理系统V1.0》等。今年以来中国医药新注册软件著作权10个。通过天眼查大数据分析，中国医药健康产业股份有限公司共对外投资了29家企业，参与招投标项目817次；财产线索方面有商标信息5条，专利信息4条，著作权信息6条；此外企业还拥有行政许可16个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","BK0250","159938","09939","BK1515","600056","BK1161","BK0010","BK0188","BK1574","BK0082","159180","BK0185","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631897586","title":"万润股份：公司收入按产品分类主要包括功能性材料、生命科学与医药两类","url":"https://stock-news.laohu8.com/highlight/detail?id=2631897586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631897586?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:06","pubTimestamp":1777539975,"startTime":"0","endTime":"0","summary":"证券之星消息，万润股份04月30日在投资者关系平台上答复投资者关心的问题。公司收入按产品分类主要包括功能性材料、生命科学与医药两类。因在电子信息材料产业、环保材料产业、新能源材料产业领域的产品均属于功能性材料，所以按产品分类划归功能性材料。另外也是为了避免各具体类别产品营业收入、营业成本、毛利率等详细信息被同业企业了解后可能产生的竞争类风险，所以按目前口径披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000054633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1515","BK0229","159938","BK0132","BK0082","002643","BK1161","09939","BK0152"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631852146","title":"4月30日山外山涨5.27%，圆信永丰医药健康A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631852146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631852146?lang=zh_cn&edition=full","pubTime":"2026-04-30 16:27","pubTimestamp":1777537668,"startTime":"0","endTime":"0","summary":"证券之星消息，4月30日山外山涨5.27%，收盘报17.17元，换手率5.96%，成交量19.05万手，成交额3.29亿元。重仓山外山的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为圆信永丰基金的圆信永丰医药健康A。圆信永丰医药健康A目前规模为2.66亿元，最新净值1.9551，较上一交易日下跌0.03%，近一年上涨23.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000053506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","150219","688410","BK1161","BK1515","09939","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631685732","title":"4月30日海创药业涨7.95%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631685732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631685732?lang=zh_cn&edition=full","pubTime":"2026-04-30 16:26","pubTimestamp":1777537618,"startTime":"0","endTime":"0","summary":"证券之星消息，4月30日海创药业涨7.95%，收盘报44.0元，换手率2.37%，成交量2.35万手，成交额9947.52万元。该股为创新药、医药概念热股。重仓海创药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A目前规模为16.53亿元，最新净值1.6892，较上一交易日上涨0.33%，近一年上涨24.55%。该公募基金现任基金经理为金笑非。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000053477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1574","688302","09939","BK1161","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631683639","title":"《Brand Finance 2026全球医药品牌价值榜》出炉 中国药企品牌价值达120.9亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631683639","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631683639?lang=zh_cn&edition=full","pubTime":"2026-04-30 15:55","pubTimestamp":1777535700,"startTime":"0","endTime":"0","summary":"当地时间2026年4月30日，《Brand Finance2026全球医药品牌价值榜》发布。报告显示，共有10家中国医药企业成功跻身全球医药50强榜单，总品牌价值达120.9亿美元。　　该报告包含全球医药品牌价值50强、全球医疗设备品牌价值25强与全球医疗保健服务品牌价值10强的权威排名。　　在上榜的中国药企中，国药集团作为中国医药品牌的领军企业，品牌价值增长10.1%至41.4亿美元，稳居全球第11位。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-30/doc-inhwhkum4189781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","09939","BK1161","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631722055","title":"新股前瞻|在研管线远水难救近渴，汇伦医药何时走出“阵痛期”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2631722055","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631722055?lang=zh_cn&edition=full","pubTime":"2026-04-30 09:58","pubTimestamp":1777514330,"startTime":"0","endTime":"0","summary":"近日，上海汇伦医药股份有限公司向港交所主板提交上市申请书，中信证券为独家保荐人。2024年，汇伦医药跻身中国化药研发实力100强，截至最后实际可行日期，拥有107项已授权专利及109项专利申请。从业绩走势来看，2023年公司营收高增，主要得益于核心产品希为纳在疫情期间的需求爆发。2023年，受COVID-19疫情期间肺部感染病例激增影响，希为纳临床需求爆发，当年贡献收入7.45亿元，占公司总营收的75.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","09939","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159610790","title":"开拓药业-B2025年度核心表现：收入激增五倍，强化创新药与功能性化妆品双线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1159610790","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159610790?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:59","pubTimestamp":1777474797,"startTime":"0","endTime":"0","summary":"开拓药业-B在2025年度实现主营业务高速增长，收入由2024年度的人民币0.50亿元大幅上升至人民币3.27亿元，同比增长约554%，主要受旗下功能性化妆品品牌“KOSHINE”销量快速增长带动。由于研发投入及无形资产减值等因素叠加，报告期内净亏损从2024年的人民币1.55亿元扩大至人民币2.00亿元，增幅约28.8%。在经营策略上，公司继续深耕皮肤科创新药研发，并加速 KX-826 及 GT20029 等外用药的商业化步伐，同时着力拓展功能性化妆品及原料业务的全球市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"开拓药业-B2025年度核心表现：收入激增五倍，强化创新药与功能性化妆品双线布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631543800","title":"创新医疗（002173）披露为鸿润医药提供800万元授信担保公告，4月29日股价上涨1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631543800","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631543800?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:19","pubTimestamp":1777472360,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，创新医疗报收于23.19元，较前一交易日上涨1.09%，最新总市值为102.33亿元。该股当日开盘22.62元，最高23.29元，最低22.6元，成交额达3.35亿元，换手率为3.44%。近日，创新医疗管理股份有限公司披露《第七届董事会2026年第二次临时会议决议公告》。公司决定为浙江鸿润医药有限公司在800万元授信额度内向招商银行绍兴诸暨支行申请贷款提供担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900068941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0077","BK1161","09939","002173","BK0114","BK1515","BK0096","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555950","title":"大亚圣象：铝板带项目终端应用于医药、食品包装，新能源动力电池，工业电力电子电容器等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631555950?lang=zh_cn&edition=full","pubTime":"2026-04-29 09:03","pubTimestamp":1777424584,"startTime":"0","endTime":"0","summary":"证券之星消息，大亚圣象(000910)04月28日在投资者关系平台上答复投资者关心的问题。投资者提问：亲爱的董秘你好，一期铝板已经投产，能简单和我们说一下，生产的铝板主要用于那些行业领域和用途么？大亚圣象回复：您好！铝板带具有质轻、耐蚀、易加工、表面美观等优点，可广泛应用于建筑、包装容器、交通运输等领域。公司一期铝板带项目主要生产高精度双零箔坯料、高性能电池箔坯料，终端应用于医药、食品包装，新能源动力电池，工业电力电子电容器等领域。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900028162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160640","BK0245","159146","159938","BK1574","000941.SH","BK1515","BK0175","09939","159875","BK1161","399941","000910"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631537129","title":"上海医药清仓中美施贵宝 高瓴系公司接盘；百洋医药一季度净利润增加近46% | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2631537129","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631537129?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:04","pubTimestamp":1777417480,"startTime":"0","endTime":"0","summary":"丨2026年4月29日星期三丨NO.1泰格医药一季度净利润同比减少70.36%4月28日，泰格医药发布2026年一季报，公司实现营业收入18.01亿元，同比增加15.17%；实现归属于上市公司股东的净利润4904.31万元，同比减少70.36%；实现归属于上市公司股东的扣除非经常性损益的净利润1.20亿元，同比增加17.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604293723254882.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604293723254882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159938","601607","09939","301015","02607","BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630889705","title":"华昊中天医药-B(02563)建议委任朱晓东为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2630889705","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630889705?lang=zh_cn&edition=full","pubTime":"2026-04-28 21:52","pubTimestamp":1777384324,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华昊中天医药-B(02563)发布公告，孟颂东博士因其主要雇主的要求已向本公司呈辞本公司独立非执行董事、薪酬与考核委员会主席及审计委员会成员职务，自2026年4月29日起生效。董事会已决议建议委任朱晓东博士为第二届董事会的独立非执行董事，任期将于第二届届满日期结束，惟须待股东于本公司股东周年大会上通过相关决议案后，方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","159938","BK1161","09939","BK1515","02563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630343326","title":"劲方医药-B(02595)：Rev Med发出函件所涉主体、产品、争议事项均与公司无关","url":"https://stock-news.laohu8.com/highlight/detail?id=2630343326","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630343326?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:36","pubTimestamp":1777351016,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，公司近期注意到若干报导，涉及 Revolution Medicines Inc.(“RevMed”)向第三方公司发出有关RAS抑制剂专利及商业秘密争议的函件。公司特此澄清并强调：Rev Med发出函件所涉主体、产品、争议事项均与公司无关，劲方Pan RAS抑制剂GFH276具备完全独立、自主原创的知识产权，不存在类似侵权或商业秘密争议风险。劲方针对Pan RAS抑制剂项目已构建全面的全球专利布局，涵盖GFH276化合物结构的专利已于2025年3月6日正式公开，专利保护期预计可至2044年。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","159938","02595","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630132145","title":"别只盯着AI！CXO龙头绩后狂飙，医药赛道要接棒？","url":"https://stock-news.laohu8.com/highlight/detail?id=2630132145","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630132145?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:12","pubTimestamp":1777349565,"startTime":"0","endTime":"0","summary":"新一轮行情蓄势待发？","market":"sh","thumbnail":"https://img3.gelonghui.com/24523-2e652654-d4de-433f-93f9-afc3a2669c93.jpg?guru_height=718&guru_width=1280&guru_size=85166","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/24523-2e652654-d4de-433f-93f9-afc3a2669c93.jpg?guru_height=718&guru_width=1280&guru_size=85166"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4574522","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","LU2125910500.SGD","BK1515","BK0132","BK1161","LU0320764599.SGD","BK1191","BK0239","LU1328615791.USD","09939","06821","LU2045819591.USD","CHAT","LU2242644610.SGD","AIPO","BK1576","LU0708995583.HKD","603127","BK1583","ARTY","LU1046422090.SGD","02359","159938","LU0052750758.USD","AGIX","BK1141","CXO","LU0348767384.USD","BK0216","LU0348766576.USD","002821","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630336631","title":"4月27日海创药业跌12.16%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630336631","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630336631?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:29","pubTimestamp":1777278550,"startTime":"0","endTime":"0","summary":"证券之星消息，4月27日海创药业跌12.16%，收盘报41.03元，换手率3.15%，成交量3.12万手，成交额1.32亿元。重仓海创药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A目前规模为16.53亿元，最新净值1.6872，较上一交易日下跌0.5%，近一年上涨24.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700029243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","688302","BK0239","09939","BK1161","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630637359","title":"港股开拓药业-B盘中涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630637359","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630637359?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:23","pubTimestamp":1777260219,"startTime":"0","endTime":"0","summary":"4月27日，开拓药业-B(09939.HK)盘中涨超8%，截至发稿涨8.86%，报2.95港元，成交额915.05万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604273719895312.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604273719895312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","09939","BK4585","BK1161","BK4588","BK1515","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126309407","title":"异动解读 | 开拓药业-B盘中大涨11.81%，因2026年度销售收入已超去年全年","url":"https://stock-news.laohu8.com/highlight/detail?id=1126309407","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126309407?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:22","pubTimestamp":1777260164,"startTime":"0","endTime":"0","summary":"开拓药业-B今日盘中股价大幅上涨11.81%，引起了市场的广泛关注。消息面上，公司此前发布公告称，自2026年开年以来，其B2C和B2B销售业务实现快速稳定增长。根据初步统计，本年度累计销售收入已超过2025年全年总额。具体数据显示，公司本年度销售收入已达约人民币3400万元，超过去年全年的3268万元，并有望完成全年超过人民币1.5亿元的目标。增长主要得益于B2C国内电商销售同比激增25倍，以及海外电商销售同比增长150%。公司自播业务启动后持续增长，本月平均日销售额近人民币10万元，并创下单日成交总额人民币40万元的纪录。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630808491","title":"前新财富医药“一姐”控诉杭州德诺电生理，索要关键协议原件15个月未果！超6亿元股权交易之争牵扯多家国资背景基金、知名创投及上市公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2630808491","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630808491?lang=zh_cn&edition=full","pubTime":"2026-04-25 18:46","pubTimestamp":1777113963,"startTime":"0","endTime":"0","summary":"近日，投资圈流传出一份由杭州德诺电生理医疗科技有限公司（简称德诺电生理）股东发出的公开信，信中针对德诺电生理的控制权转让交易提出多项质疑。《每日经济新闻》记者（简称每经记者）获悉，该文章的作者正是前新财富医药“一姐”张明芳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604253719072929.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604253719072929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09939","159938","BK1161","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629867820","title":"男子称用了10多年的学位证被告知“无效” 山东医药大学：正调查核实","url":"https://stock-news.laohu8.com/highlight/detail?id=2629867820","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629867820?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:12","pubTimestamp":1776989520,"startTime":"0","endTime":"0","summary":"据红星新闻报道，“用了十几年的学位证莫名其妙‘无效’了。”日前，展先生向红星新闻反映称，自己多年前从滨州医学院毕业后，凭借毕业证和学位证一直正常参加工作，却在去年换工作时突然被告知其学位证“无效”，导致无法顺利入职。几经了解，展先生从校方获悉，他的学位证“从未被授予”。为了弄清自己手中的学位证真假，展先生对自己进行了举报，希望能通过相关单位倒查的方式，证实学位证的真伪。","market":"us","thumbnail":"https://media.bjnews.com.cn/cover/2021/08/22/5093511165863077154.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2021/08/22/5093511165863077154.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1776988980129651.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1776988980129651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK1574","BK1515","159938","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629486439","title":"复星医药筹划出售资产；诺诚健华一季度净利润同比增长488.93%｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2629486439","media":"每日经济新闻","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629486439?lang=zh_cn&edition=full","pubTime":"2026-04-24 07:00","pubTimestamp":1776985208,"startTime":"0","endTime":"0","summary":"｜2026年4月24日星期五｜NO.1九洲药业一季度净利润1.72亿元同比减少31.22%4月23日，九洲药业公告，公司2026年第一季度实现营业收入12.01亿元，同比下降19.43%；利润总额2.20亿元，同比下降29.20%；归属于上市公司股东的净利润1.72亿元，同比减少31.22%，主要系销售业务减少所致；经营活动产生的现金流量净额1.36亿元，同比下降52.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604243716839096.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604243716839096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688428","600196","02196","159938","09939","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629583647","title":"大型医药股表现活跃，资金连续4个交易日流入医药ETF易方达（512010）","url":"https://stock-news.laohu8.com/highlight/detail?id=2629583647","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629583647?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:49","pubTimestamp":1776944992,"startTime":"0","endTime":"0","summary":"4月23日，市场多数板块回调，大型医药股表现活跃，爱尔眼科涨超5%，爱美客、新产业涨超2%，恒瑞医药、新和成涨超1%，指数层面，沪深300医药卫生指数上涨0.6%，中证创新药产业指数下跌1.1%，中证生物科技主题指数下跌1.3%，中证港股通医药卫生综合指数下跌3.7%，恒生港股通创新药指数下跌4.9%。Wind数据显示，截至昨日，跟踪沪深300医药卫生指数的医药ETF易方达(512010，联接基金A/C：001344/007883)连续4个交易日获资金净流入，合计超4亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026042300056163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","512010","BK1574","09939","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":0.0637},{"period":"1month","weight":0.1406},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.5106},{"period":"1year","weight":1.3667},{"period":"ytd","weight":0.449}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"开拓药业有限公司是一家主要从事创新药产品研发的投资控股公司。该公司产品致力于解决未满足临床需求的疾病领域，管线主要涵盖皮科（如脱发、痤疮等）及肿瘤适应症。该公司在皮科领域有两款核心药物KX-826及GT20029。该公司在其他疾病领域包括转移性去势抗性前列腺癌（mCRPC）、肝癌、特发性肺纤维化、恶性血液疾病及多种实体瘤等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.020286},{"month":2,"riseRate":0.666667,"avgChangeRate":0.174983},{"month":3,"riseRate":0.333333,"avgChangeRate":0.058562},{"month":4,"riseRate":0.666667,"avgChangeRate":0.374359},{"month":5,"riseRate":0.6,"avgChangeRate":0.045244},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.066873},{"month":7,"riseRate":0.666667,"avgChangeRate":0.132768},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.071497},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.129033},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.103242},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073526},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.185801}],"exchange":"SEHK","name":"开拓药业-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开拓药业-B,09939,开拓药业-B股票,开拓药业-B股票老虎,开拓药业-B股票老虎国际,开拓药业-B行情,开拓药业-B股票行情,开拓药业-B股价,开拓药业-B股市,开拓药业-B股票价格,开拓药业-B股票交易,开拓药业-B股票购买,开拓药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}